Nuo Therapeutics Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Stock Symbol
  • AURX

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.07
  • (As of Thursday Closing)

Nuo Therapeutics General Information

Description

Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous (patient-derived) biological materials to promote natural healing. Its primary commercial product is the Aurix System, a point-of-care technology that produces platelet-rich plasma (PRP) therapy from a patient's own blood for use in the treatment of chronic wounds.

Contact Information

Website
www.nuot.com
Formerly Known As
Cytomedix, Autologous Wound Trerapy Inc, Autologous Wound Therapy Inc
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 207A Perry Parkway
  • Suite 1
  • Gaithersburg, MD 20877
  • United States
+1 (240)
Primary Industry
Surgical Devices
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 207A Perry Parkway
  • Suite 1
  • Gaithersburg, MD 20877
  • United States
+1 (240)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuo Therapeutics Stock Performance

As of 19-Nov-2026, Nuo Therapeutics’s stock price is $1.07. Its current market cap is $52.1M with 48.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.07 $1.09 $0.77 - $2.29 $52.1M 48.6M 7.08K -$0.04

Nuo Therapeutics Financials Summary

As of 30-Sep-2026, Nuo Therapeutics has a trailing 12-month revenue of $6.03M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 61,903 94,313 64,733 22,968
Revenue 6,034 3,314 1,365 609
EBITDA (1,369) (2,354) (2,228) (3,063)
Net Income (1,899) (2,512) (2,324) (3,171)
Total Assets 2,730 1,846 1,190 1,878
Total Debt 1,841 597 164 256
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nuo Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nuo Therapeutics‘s full profile, request access.

Request a free trial

Nuo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chron
Surgical Devices
Gaithersburg, MD
10 As of 2025

Marietta, GA
 

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nuo Therapeutics Competitors (7)

One of Nuo Therapeutics’s 7 competitors is Mimedx Group, a Corporation company based in Marietta, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mimedx Group Corporation Marietta, GA
TELA Bio Formerly VC-backed Malvern, PA
Sanara MedTech Corporation Fort Worth, TX
Mölnlycke Health Care Private Equity-Backed Mölndal, Sweden
Reapplix Venture Capital-Backed Birkerod, Denmark
You’re viewing 5 of 7 competitors. Get the full list »

Nuo Therapeutics Patents

Nuo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010308416-A1 Kit for separation of biological fluids Active 13-Oct-2009
AU-2010308416-B2 Kit for separation of biological fluids Inactive 13-Oct-2009
CA-2775352-A1 Kit for separation of biological fluids Active 13-Oct-2009
CA-2775352-C Kit for separation of biological fluids Active 13-Oct-2009
EP-2488229-A2 Kit for separation of biological fluids Active 13-Oct-2009 B01L3/5021
To view Nuo Therapeutics’s complete patent history, request access »

Nuo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuo Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nuo Therapeutics‘s full profile, request access.

Request a free trial

Nuo Therapeutics Investments & Acquisitions (3)

Nuo Therapeutics’s most recent deal was a Merger/Acquisition with Aldagen for . The deal was made on 09-Feb-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aldagen 09-Feb-2012 Merger/Acquisition Drug Discovery
Sorin Group (blood processing kits) 12-Apr-2010 Corporate Asset Purchase Buildings and Property
Informatix Holdings 04-Nov-1999 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Nuo Therapeutics’s complete investments and acquisitions history, request access »

Nuo Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Nuo Therapeutics’s complete esg history, request access »

Nuo Therapeutics FAQs

  • When was Nuo Therapeutics founded?

    Nuo Therapeutics was founded in 1987.

  • Where is Nuo Therapeutics headquartered?

    Nuo Therapeutics is headquartered in Gaithersburg, MD.

  • What is the size of Nuo Therapeutics?

    Nuo Therapeutics has 10 total employees.

  • What industry is Nuo Therapeutics in?

    Nuo Therapeutics’s primary industry is Surgical Devices.

  • Is Nuo Therapeutics a private or public company?

    Nuo Therapeutics is a Public company.

  • What is Nuo Therapeutics’s stock symbol?

    The ticker symbol for Nuo Therapeutics is AURX.

  • What is the current stock price of Nuo Therapeutics?

    As of 19-Nov-2026 the stock price of Nuo Therapeutics is $1.07.

  • What is the current market cap of Nuo Therapeutics?

    The current market capitalization of Nuo Therapeutics is $52.1M.

  • What is Nuo Therapeutics’s current revenue?

    The trailing twelve month revenue for Nuo Therapeutics is $6.03M.

  • Who are Nuo Therapeutics’s competitors?

    Mimedx Group, TELA Bio, Sanara MedTech, Mölnlycke Health Care, and Reapplix are some of the 7 competitors of Nuo Therapeutics.

  • What is Nuo Therapeutics’s annual earnings per share (EPS)?

    Nuo Therapeutics’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process